Intellipharmaceutics International Inc. (IPCI)

[fabius]

Samsa,

1- yes, Purdue can sue Cigna, but they now have time running against them, at lest on this side (the more time passes before having a final decision and the less oxycontin is sold via the CIGNA users). if just another of the big insurers follows then it can become interesting for IPCI

2- competition could try to take advantage, but I give more weight to having Purdue as a partner (potentially speaking) then being 6-9 months behind a competitor; Purdue commercial power is impressive.

3- IPCI management (LoL) being unable to strategically address issues and opportunities is something they NEED to change immediately